ENCOMPASS HEALTH CORP (EHC) Fundamental Analysis & Valuation
NYSE:EHC • US29261A1007
Current stock price
100.37 USD
+0.07 (+0.07%)
At close:
100.37 USD
0 (0%)
After Hours:
This EHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. EHC Profitability Analysis
1.1 Basic Checks
- In the past year EHC was profitable.
- EHC had a positive operating cash flow in the past year.
- In the past 5 years EHC has always been profitable.
- Each year in the past 5 years EHC had a positive operating cash flow.
1.2 Ratios
- EHC's Return On Assets of 7.97% is amongst the best of the industry. EHC outperforms 91.09% of its industry peers.
- EHC's Return On Equity of 23.16% is amongst the best of the industry. EHC outperforms 90.10% of its industry peers.
- EHC's Return On Invested Capital of 13.45% is amongst the best of the industry. EHC outperforms 90.10% of its industry peers.
- EHC had an Average Return On Invested Capital over the past 3 years of 12.10%. This is above the industry average of 8.98%.
- The 3 year average ROIC (12.10%) for EHC is below the current ROIC(13.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.97% | ||
| ROE | 23.16% | ||
| ROIC | 13.45% |
ROA(3y)6.87%
ROA(5y)6.28%
ROE(3y)22.1%
ROE(5y)21.67%
ROIC(3y)12.1%
ROIC(5y)10.97%
1.3 Margins
- EHC has a Profit Margin of 9.51%. This is amongst the best in the industry. EHC outperforms 94.06% of its industry peers.
- In the last couple of years the Profit Margin of EHC has grown nicely.
- The Operating Margin of EHC (17.74%) is better than 97.03% of its industry peers.
- In the last couple of years the Operating Margin of EHC has grown nicely.
- EHC has a Gross Margin of 95.71%. This is amongst the best in the industry. EHC outperforms 99.01% of its industry peers.
- In the last couple of years the Gross Margin of EHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.74% | ||
| PM (TTM) | 9.51% | ||
| GM | 95.71% |
OM growth 3Y6.98%
OM growth 5Y3.59%
PM growth 3Y15.32%
PM growth 5Y3.68%
GM growth 3Y0.13%
GM growth 5Y0.11%
2. EHC Health Analysis
2.1 Basic Checks
- EHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, EHC has less shares outstanding
- EHC has more shares outstanding than it did 5 years ago.
- EHC has a better debt/assets ratio than last year.
2.2 Solvency
- EHC has an Altman-Z score of 2.88. This is not the best score and indicates that EHC is in the grey zone with still only limited risk for bankruptcy at the moment.
- EHC has a Altman-Z score of 2.88. This is in the better half of the industry: EHC outperforms 63.37% of its industry peers.
- EHC has a debt to FCF ratio of 5.67. This is a neutral value as EHC would need 5.67 years to pay back of all of its debts.
- EHC has a Debt to FCF ratio (5.67) which is comparable to the rest of the industry.
- EHC has a Debt/Equity ratio of 1.00. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.00, EHC perfoms like the industry average, outperforming 40.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 5.67 | ||
| Altman-Z | 2.88 |
ROIC/WACC1.65
WACC8.16%
2.3 Liquidity
- EHC has a Current Ratio of 1.08. This is a normal value and indicates that EHC is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.08, EHC is doing worse than 60.40% of the companies in the same industry.
- A Quick Ratio of 1.08 indicates that EHC should not have too much problems paying its short term obligations.
- The Quick ratio of EHC (1.08) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 |
3. EHC Growth Analysis
3.1 Past
- EHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.25%, which is quite impressive.
- EHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.57% yearly.
- EHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.46%.
- Measured over the past years, EHC shows a quite strong growth in Revenue. The Revenue has been growing by 10.72% on average per year.
EPS 1Y (TTM)23.25%
EPS 3Y16.99%
EPS 5Y13.57%
EPS Q2Q%24.79%
Revenue 1Y (TTM)10.46%
Revenue growth 3Y10.92%
Revenue growth 5Y10.72%
Sales Q2Q%9.94%
3.2 Future
- The Earnings Per Share is expected to grow by 9.21% on average over the next years. This is quite good.
- EHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.55% yearly.
EPS Next Y10.23%
EPS Next 2Y9.44%
EPS Next 3Y9.87%
EPS Next 5Y9.21%
Revenue Next Year8.33%
Revenue Next 2Y8.22%
Revenue Next 3Y8.07%
Revenue Next 5Y7.55%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. EHC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 18.38, which indicates a rather expensive current valuation of EHC.
- Compared to the rest of the industry, the Price/Earnings ratio of EHC indicates a somewhat cheap valuation: EHC is cheaper than 71.29% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 25.70. EHC is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 16.68, the valuation of EHC can be described as correct.
- 69.31% of the companies in the same industry are more expensive than EHC, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of EHC to the average of the S&P500 Index (23.84), we can say EHC is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.38 | ||
| Fwd PE | 16.68 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, EHC is valued a bit cheaper than 75.25% of the companies in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as EHC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.72 | ||
| EV/EBITDA | 8.91 |
4.3 Compensation for Growth
- EHC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- EHC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.8
PEG (5Y)1.35
EPS Next 2Y9.44%
EPS Next 3Y9.87%
5. EHC Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.76%, EHC is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.49, EHC pays a better dividend. On top of this EHC pays more dividend than 84.16% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, EHC's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.76% |
5.2 History
- The dividend of EHC decreases each year by -8.92%.
- EHC has paid a dividend for at least 10 years, which is a reliable track record.
- EHC has decreased its dividend recently.
Dividend Growth(5Y)-8.92%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- EHC pays out 12.59% of its income as dividend. This is a sustainable payout ratio.
DP12.59%
EPS Next 2Y9.44%
EPS Next 3Y9.87%
EHC Fundamentals: All Metrics, Ratios and Statistics
100.37
+0.07 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)04-22 2026-04-22/amc
Inst Owners101.43%
Inst Owner Change6%
Ins Owners1.2%
Ins Owner Change-3.37%
Market Cap9.98B
Revenue(TTM)5.94B
Net Income(TTM)564.70M
Analysts87.5
Price Target144.07 (43.54%)
Short Float %3.83%
Short Ratio2.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.76% |
Yearly Dividend0.71
Dividend Growth(5Y)-8.92%
DP12.59%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-01 2026-04-01 (0.19)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.65%
Min EPS beat(2)1.94%
Max EPS beat(2)11.35%
EPS beat(4)4
Avg EPS beat(4)10.51%
Min EPS beat(4)1.94%
Max EPS beat(4)14.64%
EPS beat(8)8
Avg EPS beat(8)11.26%
EPS beat(12)12
Avg EPS beat(12)13.85%
EPS beat(16)15
Avg EPS beat(16)10.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.95%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)-0.73%
Revenue beat(4)2
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.16%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)8
Avg Revenue beat(12)0.34%
Revenue beat(16)10
Avg Revenue beat(16)-2.28%
PT rev (1m)0.65%
PT rev (3m)0.65%
EPS NQ rev (1m)0.21%
EPS NQ rev (3m)0.21%
EPS NY rev (1m)2.55%
EPS NY rev (3m)2.55%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)-0.44%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-0.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.38 | ||
| Fwd PE | 16.68 | ||
| P/S | 1.68 | ||
| P/FCF | 22.72 | ||
| P/OCF | 8.49 | ||
| P/B | 4.09 | ||
| P/tB | 12.28 | ||
| EV/EBITDA | 8.91 |
EPS(TTM)5.46
EY5.44%
EPS(NY)6.02
Fwd EY6%
FCF(TTM)4.42
FCFY4.4%
OCF(TTM)11.82
OCFY11.78%
SpS59.7
BVpS24.52
TBVpS8.17
PEG (NY)1.8
PEG (5Y)1.35
Graham Number54.89
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.97% | ||
| ROE | 23.16% | ||
| ROCE | 16.84% | ||
| ROIC | 13.45% | ||
| ROICexc | 13.7% | ||
| ROICexgc | 18.64% | ||
| OM | 17.74% | ||
| PM (TTM) | 9.51% | ||
| GM | 95.71% | ||
| FCFM | 7.4% |
ROA(3y)6.87%
ROA(5y)6.28%
ROE(3y)22.1%
ROE(5y)21.67%
ROIC(3y)12.1%
ROIC(5y)10.97%
ROICexc(3y)12.29%
ROICexc(5y)11.11%
ROICexgc(3y)17.03%
ROICexgc(5y)16.37%
ROCE(3y)15.15%
ROCE(5y)13.74%
ROICexgc growth 3Y8.96%
ROICexgc growth 5Y3.92%
ROICexc growth 3Y11.11%
ROICexc growth 5Y12.23%
OM growth 3Y6.98%
OM growth 5Y3.59%
PM growth 3Y15.32%
PM growth 5Y3.68%
GM growth 3Y0.13%
GM growth 5Y0.11%
F-Score9
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 5.67 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 224.58% | ||
| Cap/Sales | 12.41% | ||
| Interest Coverage | 7.91 | ||
| Cash Conversion | 85.13% | ||
| Profit Quality | 77.78% | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.88 |
F-Score9
WACC8.16%
ROIC/WACC1.65
Cap/Depr(3y)217.31%
Cap/Depr(5y)221.3%
Cap/Sales(3y)12.17%
Cap/Sales(5y)12.73%
Profit Quality(3y)77.97%
Profit Quality(5y)63.82%
High Growth Momentum
Growth
EPS 1Y (TTM)23.25%
EPS 3Y16.99%
EPS 5Y13.57%
EPS Q2Q%24.79%
EPS Next Y10.23%
EPS Next 2Y9.44%
EPS Next 3Y9.87%
EPS Next 5Y9.21%
Revenue 1Y (TTM)10.46%
Revenue growth 3Y10.92%
Revenue growth 5Y10.72%
Sales Q2Q%9.94%
Revenue Next Year8.33%
Revenue Next 2Y8.22%
Revenue Next 3Y8.07%
Revenue Next 5Y7.55%
EBIT growth 1Y21.82%
EBIT growth 3Y18.67%
EBIT growth 5Y14.7%
EBIT Next Year42.87%
EBIT Next 3Y19.43%
EBIT Next 5YN/A
FCF growth 1Y21.9%
FCF growth 3Y53.39%
FCF growth 5Y8.18%
OCF growth 1Y17.23%
OCF growth 3Y18.54%
OCF growth 5Y10.78%
ENCOMPASS HEALTH CORP / EHC Fundamental Analysis FAQ
What is the fundamental rating for EHC stock?
ChartMill assigns a fundamental rating of 6 / 10 to EHC.
What is the valuation status for EHC stock?
ChartMill assigns a valuation rating of 5 / 10 to ENCOMPASS HEALTH CORP (EHC). This can be considered as Fairly Valued.
Can you provide the profitability details for ENCOMPASS HEALTH CORP?
ENCOMPASS HEALTH CORP (EHC) has a profitability rating of 9 / 10.
What is the financial health of ENCOMPASS HEALTH CORP (EHC) stock?
The financial health rating of ENCOMPASS HEALTH CORP (EHC) is 4 / 10.
Is the dividend of ENCOMPASS HEALTH CORP sustainable?
The dividend rating of ENCOMPASS HEALTH CORP (EHC) is 4 / 10 and the dividend payout ratio is 12.59%.